 Minyanville.com |
GlaxoSmithKline Ties Up Loose Ends With Relovair
Minyanville.com The FDA recently made more stringent requirements for drugs that contain long-acting beta agonists for the treatment of asthma due to safety concerns. … Glaxo, Theravance report Relovair safety data GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results GSK and Theravance announce combination ICS/LABA Phase II results in the … |
View full post on asthma – Google News